Loading...

Photocure ASA

PHCUFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$7.07
$0.00(0.00%)
U.S. Market opens in 7h 36m

Photocure ASA Fundamental Analysis

Photocure ASA (PHCUF) shows weak financial fundamentals with a PE ratio of -1133.28, profit margin of -0.29%, and ROE of -0.32%. The company generates $0.5B in annual revenue with weak year-over-year growth of 1.37%.

Key Strengths

Cash Position127.37%
PEG Ratio-0.01
Current Ratio3.64

Areas of Concern

ROE-0.32%
We analyze PHCUF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 32.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
32.5/100

We analyze PHCUF's fundamental strength across five key dimensions:

Efficiency Score

Weak

PHCUF struggles to generate sufficient returns from assets.

ROA > 10%
-0.22%

Valuation Score

Excellent

PHCUF trades at attractive valuation levels.

PE < 25
-1133.28
PEG Ratio < 2
-0.01

Growth Score

Moderate

PHCUF shows steady but slowing expansion.

Revenue Growth > 5%
1.37%
EPS Growth > 10%
66.47%

Financial Health Score

Excellent

PHCUF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
3.64

Profitability Score

Weak

PHCUF struggles to sustain strong margins.

ROE > 15%
-31.88%
Net Margin ≥ 15%
-0.29%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is PHCUF Expensive or Cheap?

P/E Ratio

PHCUF trades at -1133.28 times earnings. This suggests potential undervaluation.

-1133.28

PEG Ratio

When adjusting for growth, PHCUF's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Photocure ASA at 3.58 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.58

EV/EBITDA

Enterprise value stands at 27.97 times EBITDA. This signals the market has high growth expectations.

27.97

How Well Does PHCUF Make Money?

Net Profit Margin

For every $100 in sales, Photocure ASA keeps $-0.29 as profit after all expenses.

-0.29%

Operating Margin

Core operations generate 10.21 in profit for every $100 in revenue, before interest and taxes.

10.21%

ROE

Management delivers $-0.32 in profit for every $100 of shareholder equity.

-0.32%

ROA

Photocure ASA generates $-0.22 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.22%

Following the Money - Real Cash Generation

Operating Cash Flow

Photocure ASA generates limited operating cash flow of $31.40M, signaling weaker underlying cash strength.

$31.40M

Free Cash Flow

Photocure ASA produces free cash flow of $28.79M, offering steady but limited capital for shareholder returns and expansion.

$28.79M

FCF Per Share

Each share generates $1.08 in free cash annually.

$1.08

FCF Yield

PHCUF converts 1.65% of its market value into free cash.

1.65%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1133.28

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.58

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.27

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.64

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.09

vs 25 benchmark

How PHCUF Stacks Against Its Sector Peers

MetricPHCUF ValueSector AveragePerformance
P/E Ratio-1133.2829.88 Better (Cheaper)
ROE-0.32%682.00% Weak
Net Margin-0.29%-46037.00% (disorted) Weak
Debt/Equity0.000.42 Strong (Low Leverage)
Current Ratio3.644.49 Strong Liquidity
ROA-0.22%-16420.00% (disorted) Weak

PHCUF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Photocure ASA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

91.76%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

93.74%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

126.29%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ